| __timestamp | Bio-Techne Corporation | Grifols, S.A. |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 180753000 |
| Thursday, January 1, 2015 | 40853000 | 224193000 |
| Friday, January 1, 2016 | 45187000 | 197617000 |
| Sunday, January 1, 2017 | 53514000 | 288320000 |
| Monday, January 1, 2018 | 55329000 | 240661000 |
| Tuesday, January 1, 2019 | 62413000 | 276018000 |
| Wednesday, January 1, 2020 | 65192000 | 294216000 |
| Friday, January 1, 2021 | 70603000 | 354881000 |
| Saturday, January 1, 2022 | 87140000 | 361140000 |
| Sunday, January 1, 2023 | 92493000 | 330551000 |
| Monday, January 1, 2024 | 96664000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of innovation and future growth. Bio-Techne Corporation and Grifols, S.A. have been at the forefront of this race since 2014. Bio-Techne's R&D expenses have surged by over 200% from 2014 to 2023, reflecting a robust commitment to innovation. In contrast, Grifols, S.A. has consistently allocated a larger portion of its budget to R&D, peaking in 2022 with a 100% increase from 2014. However, 2024 data for Grifols is missing, leaving a gap in the trend. This comparison highlights the strategic differences in how these companies prioritize R&D, with Bio-Techne showing a steady increase and Grifols maintaining a higher baseline. As the biotech industry evolves, these investments will likely play a crucial role in shaping the future landscape.
Research and Development: Comparing Key Metrics for Eli Lilly and Company and Grifols, S.A.
R&D Insights: How AstraZeneca PLC and Grifols, S.A. Allocate Funds
Comparing Innovation Spending: Novartis AG and Bio-Techne Corporation
R&D Insights: How Bio-Techne Corporation and Lantheus Holdings, Inc. Allocate Funds
Bio-Techne Corporation or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Research and Development Investment: Bio-Techne Corporation vs CRISPR Therapeutics AG
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Perrigo Company plc
Analyzing R&D Budgets: Bio-Techne Corporation vs MorphoSys AG
Research and Development Expenses Breakdown: Grifols, S.A. vs TG Therapeutics, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Amicus Therapeutics, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Geron Corporation
Analyzing R&D Budgets: Grifols, S.A. vs Xencor, Inc.